Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 536.45 (2026-11-18)

Non-Operating Income/Expense (Quarterly)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

Vertex Pharmaceuticals Incorporated (VRTX) had Non-Operating Income/Expense of $70.50M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$3.44B
$653.60M
$526.10M
$2.91B
$2.73B
$712.90M
Non-Operating Income/Expense
$70.50M
$783.40M
$783.40M
$653.60M
$653.60M
$653.60M
$653.60M
$712.90M
$782.10M
253.50M
255.20M
$2.58
$2.56
Balance Sheet Financials
$11.69B
$1.71B
$21.05B
$32.74B
$5.00B
$3.50B
$6.83B
$11.83B
$20.91B
$9.97B
$20.91B
253.52M
Cash Flow Statement Financials
$3.20B
$-6.58B
$3.33B
$5.09B
$4.99B
$-99.20M
$511.00M
--
--
Fundamental Metrics & Ratios
2.34
--
--
0.14
0.22
84.71%
20.72%
20.72%
--
22.77%
19.00%
$2.85B
--
--
--
0.11
0.23
1.49
60.45
3.13%
6.56%
2.00%
2.68%
$82.47
$11.18
$12.53